Fulcrum Therapeutics Inc (FULC)
Healthcare
Biotechnology
3.70 $
+3.6%
vs. previous close
Closing price · As of: 3. Aug 2026
Fulcrum Therapeutics Inc (FULC) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -16 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -23 | -23 | -25 | 59 | -19 | -17 | -15 | -14 | -14 | -17 | -19 | -16 | -66 | |
| 0.5 | 0.5 | 0.5 | 0.4 | 0.4 | 0.4 | 0.4 | 0.3 | 0.3 | 0.3 | 0.3 | 0.2 | 1.2 | |
| 3.7 | 3.4 | 3.9 | 4.3 | 3.8 | 2.5 | 3.2 | 2.9 | 3.4 | 3.1 | 3.9 | 3.3 | 14 | |
| -1.6 | -1.0 | -1.6 | -0.1 | -0.4 | -2.1 | -0.2 | 1.3 | 2.3 | 0.5 | -3.3 | 3.3 | 2.8 | |
| 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.2 | 0.0 | 0.1 | 0.1 | 0.2 | 0.0 | 0.1 | 0.4 | |
| 19 | 18 | 38 | -13 | 4.4 | 2.3 | -0.8 | 14 | 19 | -1.0 | -128 | 14 | -97 | |
| 118 | 0.3 | 1.7 | 0.4 | 0.6 | 0.1 | 0.0 | 0.3 | 0.1 | 168 | -0.3 | 0.4 | 168 | |
| -3.9 | -4.5 | 14 | 47 | -14 | -14 | -16 | 0.4 | 4.5 | 150 | -147 | -1.9 | 5.8 | |
| -23 | -23 | -25 | 59 | -19 | -17 | -15 | -14 | -14 | -17 | -19 | -16 | -66 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.